Processing

Please wait...

Settings

Settings

Goto Application

1. WO2013162047 - THERAPEUTIC AGENT FOR SECONDARY HYPERPARATHYROIDISM

Publication Number WO/2013/162047
Publication Date 31.10.2013
International Application No. PCT/JP2013/062682
International Filing Date 23.04.2013
IPC
A61K 31/593 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
59Compounds containing 9,10-seco-cyclopentahydro- phenanthrene ring systems
5939,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61P 19/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
A61P 19/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
08for bone diseases, e.g. rachitism, Paget's disease
10for osteoporosis
A61P 43/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
CPC
A61K 31/593
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
A61P 19/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
A61P 19/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
08for bone diseases, e.g. rachitism, Paget's disease
10for osteoporosis
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P 5/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
5Drugs for disorders of the endocrine system
18of the parathyroid hormones
20for decreasing, blocking or antagonising the activity of PTH
Applicants
  • 帝人ファーマ株式会社 TEIJIN PHARMA LIMITED [JP]/[JP]
Inventors
  • 中山 保典 NAKAYAMA, Yasunori
  • 田野倉 章 TANOKURA, Akira
  • 千田 貴之 CHIDA, Takayuki
  • 落合 鋭士 OCHIAI, Eiji
  • 石田 美幸 ISHIDA, Miyuki
  • 鈴木 麻美 SUZUKI, Mami
Agents
  • 為山 太郎 TAMEYAMA, Taro
Priority Data
2012-09869424.04.2012JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) THERAPEUTIC AGENT FOR SECONDARY HYPERPARATHYROIDISM
(FR) AGENT THÉRAPEUTIQUE POUR HYPERPARATHYROÏDISME SECONDAIRE
(JA) 二次性副甲状腺機能亢進症治療剤
Abstract
(EN)
The present invention provides a therapeutic agent for secondary hyperparathyroidism which comprises as an active component a vitamin D3 derivative represented by formula (1) or a medically acceptable solvate thereof.
(FR)
La présente invention concerne un agent thérapeutique pour hyperparathyroïdisme secondaire qui comprend, en tant que composant actif, un dérivé de vitamine D3 représenté par la formule (1) ou son solvate médicalement acceptable.
(JA)
本発明は、下記式(1)で表されるビタミンD誘導体またはその医薬上許容される溶媒和物を有効成分として含有する、二次性副甲状腺機能亢進症治療剤に関する。
Latest bibliographic data on file with the International Bureau